330 filings
Page 6 of 17
8-K
poa xki9ss
31 Jul 12
Other Events
12:00am
424B5
sseme390
31 Jul 12
Prospectus supplement for primary offering
12:00am
8-K
zha5z910j
20 Jun 12
Idenix Announces Positive Clinical Data for HCV Drug Candidates IDX184 and IDX719
12:00am
S-8
eh52dxtoif2pdk
11 Jun 12
Registration of securities for employees
12:00am
8-K
j0ihgmk pe2
8 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
yrfy ujcapev2tj96g
21 May 12
Departure of Directors or Certain Officers
12:00am
CT ORDER
td2uykf
3 May 12
Confidential treatment order
12:00am
8-K
ji0mbpxmozu1 s7wgrvh
2 May 12
Idenix Pharmaceuticals Reports First Quarter 2012 Financial
12:00am
ARS
h5f4ltsdm hs4t
26 Apr 12
Annual report to shareholders
12:00am
8-K
01wg xz88
24 Apr 12
Other Events
12:00am
8-K
ihidgiko6mt 19
29 Mar 12
Departure of Directors or Certain Officers
12:00am
CT ORDER
69uk7 8p7f28gk7z
23 Mar 12
Confidential treatment order
12:00am
8-K
dcqgmao srdasakn
6 Mar 12
Board and Appoints Michael Wyzga to Its Board of Directors
12:00am
8-K
nx0yn7zh4oyn1os97
23 Feb 12
Idenix Pharmaceuticals Reports Fourth Quarter and Year End 2011 Financial Results and Provides Pipeline Update
12:00am
8-K
e9s54mlc
6 Feb 12
Departure of Directors or Certain Officers
12:00am
8-K
9j9obmzaa61 mjt
3 Feb 12
Other Events
12:00am
8-K
mvqty
9 Jan 12
Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
12:00am